Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 1
1994 1
1996 1
1997 1
2000 1
2001 2
2002 4
2003 3
2004 5
2005 3
2007 1
2008 3
2009 3
2010 2
2011 7
2012 11
2013 7
2014 9
2015 9
2016 10
2017 13
2018 14
2019 13
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 31498767

115 results
Results by year
Filters applied: . Clear all
Page 1
ACE inhibitors and ARBs: Managing potassium and renal function.
Momoniat T, Ilyas D, Bhandari S. Momoniat T, et al. Cleve Clin J Med. 2019 Sep;86(9):601-607. doi: 10.3949/ccjm.86a.18024. Cleve Clin J Med. 2019. PMID: 31498767 Free article. Review.
Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
Ahmed A. Ahmed A. J Am Geriatr Soc. 2002 Jul;50(7):1297-300. doi: 10.1046/j.1532-5415.2002.50321.x. J Am Geriatr Soc. 2002. PMID: 12133029
Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, Arnlov J, Lund LH, Inker LA, Coresh J, Carrero JJ, Grams ME. Bandak G, et al. J Am Heart Assoc. 2017 Jul 19;6(7):e005428. doi: 10.1161/JAHA.116.005428. J Am Heart Assoc. 2017. PMID: 28724651 Free PMC article.
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF. Heerspink HJ, et al. Eur J Prev Cardiol. 2014 Mar;21(3):299-309. doi: 10.1177/2047487313510678. Epub 2013 Nov 4. Eur J Prev Cardiol. 2014. PMID: 24191305 Clinical Trial.
[Hyperkalemia as a limiting factor in the use of drugs that block the Renin Angiotensin Aldosterone System (RAAS)].
Santoro A, Mandreoli M. Santoro A, et al. G Ital Nefrol. 2018 May;35(3):2018-vol3. G Ital Nefrol. 2018. PMID: 29786183 Review. Italian.
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG. Fang G, et al. Pharmacotherapy. 2018 Jan;38(1):29-41. doi: 10.1002/phar.2051. Epub 2017 Dec 11. Pharmacotherapy. 2018. PMID: 29059475 Free PMC article.
Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension.
Kovesdy CP, Appel LJ, Grams ME, Gutekunst L, McCullough PA, Palmer BF, Pitt B, Sica DA, Townsend RR. Kovesdy CP, et al. Am J Kidney Dis. 2017 Dec;70(6):844-858. doi: 10.1053/j.ajkd.2017.09.003. Epub 2017 Oct 10. Am J Kidney Dis. 2017. PMID: 29029808
Hyperkalemia and renal function during monotherapy and dual renin-angiotensin blockade in the community setting.
Kurnik D, Vesterman-Landes J, Bialik M, Katzir I, Lomnicky Y, Halkin H, Loebstein R. Kurnik D, et al. Clin Ther. 2011 Apr;33(4):456-64. doi: 10.1016/j.clinthera.2011.04.011. Clin Ther. 2011. PMID: 21635991
Blood pressure medications: ACE-I/ARB and chronic kidney disease.
Han H. Han H. J Ren Nutr. 2013 Nov;23(6):e105-7. doi: 10.1053/j.jrn.2013.08.003. J Ren Nutr. 2013. PMID: 24209897 No abstract available.
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
Maddirala S, Khan A, Vincent A, Lau K. Maddirala S, et al. Am J Med Sci. 2008 Oct;336(4):330-5. doi: 10.1097/MAJ.0b013e3181836ac7. Am J Med Sci. 2008. PMID: 18854676
115 results
Jump to page
Feedback